Michael J. McGINITY,Feng ZHANG,John R. FLOYD,James W. McGINITY
申请号：
US15928057
公开号：
US20180311157A1
申请日:
2018.03.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
